Premium Reports
Contact KLAS
 Download Report Brief  Download Full Report    Zoom in charts

Preferences

   Bookmark

Related Series

PACS 2020
|
2020
PACS 2018
|
2018
PACS 2017
|
2017
PACS 2015
|
2015
PACS Technology 2013
|
2013
Community and Ambulatory PACS 2012
|
2012
PACS 2011
|
2011
Ambulatory RIS/PACS
|
2011
A Read on PACS
|
2010
The New PACS Market
|
2009
Ambulatory PACS 2008
|
2008
Community Hospital PACS 2008
|
2008
PACS - Acute Care 2008
|
2008
Ambulatory PACS 2007
|
2007
Community Hospital PACS 2007
|
2007
Ambulatory PACS 2006
|
2006
Community PACS 2006
|
2006
Acute Care PACS 2006
|
2006
PACS - Ambulatory/Imaging Center Report 2005
|
2005
PACS - Community Hospital Report 2005
|
2005
PACS - Acute Care Large Study 2005
|
2005

Related Segments

 End chart zoom
PACS 2022 PACS 2022
* A page refresh may be necessary to see the updated image

PACS 2022
Changing Market Leads to Volatility among Large- to Small-Volume Organizations

author - Monique Rasband
Author
Monique Rasband
author - Jonathan Christensen
Author
Jonathan Christensen
author - Sidney Tate
Author
Sidney Tate
 
November 8, 2022 | Read Time: 8  minutes

The US PACS market is poised for change. Several vendors have made or undergone acquisitions, and some vendors have large customer bases still on legacy solutions. Over 30% of the 368 organizations interviewed for this report are at risk of replacing their current vendor, and organizations are looking for vendor partners to advance their enterprise imaging strategies. Further, industry-wide staff shortages have led to support and innovation challenges among PACS vendors. This report examines how these vendors have addressed this shifting market’s challenges and met the needs of customers with large volumes (300,000+ studies per year) and small/midsize volumes (<300,000 studies per year).

Note: Most of these vendors also have broad enterprise imaging offerings. KLAS’ updated Enterprise Imaging 2022 report covering these offerings is planned to publish in Q4 of 2022.

Sectra Maintains Leading Customer Satisfaction across Large & Small Volumes; Early Indicators of Culture Shift

Sectra has led the PACS market in customer satisfaction for several years. Large- and small-volume customers view the PACS technology as top tier, stable, rich in intuitive features, and easy to customize. Sectra is further set apart from other vendors by their relationships and customer-centric culture, which is felt in interactions with account executives and deployment teams. Despite this, 20 of the 42 interviewed Sectra customers note a shift away from Sectra’s historically customer-focused support, citing slower responses, unresolved tickets, and a greater focus on sales than support. These issues are affected by growing pains, turnover, and staff shortages (a common struggle for nearly all PACS vendors). Still, some customers are hopeful Sectra will turn these issues around, and Sectra has the least replacement vulnerability of measured vendors.

Signs of Improvement from Fujifilm & Merative (IBM) Due to Increased Engagement

Amid mostly negative trends in vendor performance through the PACS market, enterprise imaging players Fujifilm and Merative are showing early signs of improvement. Fujifilm customers of all volumes are largely satisfied with Synapse’s ease of use and flexibility, though large-volume sites more often report needing additional functionalities and fixes. Dissatisfied customers cite bumpy upgrades and unmet timelines for delivering new technology, leading some to consider other options. Many clients are hopeful Fujifilm will deliver needed functionalities and their promise of a unified radiology/cardiology platform. This optimism is partly thanks to an increased sense of engagement; some recent respondents report having more individual contacts and executive engagement (in contrast to customers who feel they drive the vendor relationship).

Customers of all volumes find their needs met by Merge PACS from Merative—a new company from Francisco Partners, who recently acquired many IBM Watson Health assets. The PACS has a strong GUI and is flexible, but the lack of development has led to the technology feeling dated. Preacquisition, customers (particularly large organizations) were starting to experience more regular vendor engagement and quality, timely support—an improvement to previous relationship difficulties after IBM acquired Merge PACS. Moving forward, customers hope Merative will deliver an improved experience, innovative technology, and renewed energy into Merge PACS. Of note, Agfa HealthCare has also seen some improvement, which is addressed later in the report.

vendor performance score trending and respondent sizing large and small volume customer base

For Philips Vue PACS & INFINITT, Satisfaction Gap Widens between Large and Small Customers

Philips and INFINITT both see widening gaps between large- and small-volume customers but in different directions. Philips Vue PACS performs well among small/midsize organizations (the majority of their customers), who feel the PACS is easy to use, stable, and highly functional for radiologists. Large-volume sites report more inconsistency—some are highly satisfied, while others find Vue PACS unstable and buggy. A core complaint across volumes is the lack of product development, and this (combined with difficult upgrades and integrations) has especially eroded satisfaction for large-volume customers. Support quality also varies; several respondents mention the need for greater executive involvement. INFINITT also has a mostly small-volume customer base, but they have expanded into larger-volume facilities. Most view the PACS as stable and easy to use, if basic, and small/midsize-volume customers who have moved to the cloud version report smooth transitions and high satisfaction. As INFINITT has more heavily partnered and engaged with large-volume customers, some small-volume customers have felt left behind; they cite slower response times, lower proactivity, and more upgrade issues. Some are optimistic that support will improve as INFINITT works through their growth.

Support Dips for Intelerad Customers amid Acquisitions; Change Healthcare Customers Unsure of Vendor’s Future

Over the last two years, Intelerad has acquired multiple imaging companies and seen turnover among their teams. Amid these changes, most small/midsize-volume organizations still report satisfaction with IntelePACS’ stability, ease of use, and robust radiologist tool set; large-volume users are satisfied with the PACS but more frequently note antiquated technology and lacking development. Across all volumes, the support has dropped—response times have lengthened dramatically, and customers report frequent nickel-and-diming. Small-volume organizations feel they have lost touch with the vendor, though large-volume sites still have vendor ties through account managers. Change Healthcare is a consistent market player across all volumes. Customers’ needs are met by the easy-to-use, reliable, and scalable PACS, though they note development for the on-premises solution has lagged as the vendor has focused their ongoing strategy on the cloud. Customers’ support experiences vary from quick and helpful to slow and impersonal, and many report feeling nickel-and-dimed by the vendor. Along with the recently finalized acquisition by UnitedHealth Group, these issues have caused customers to question the future of the product and their relationship with the vendor.

product and relationship scores large and small volume customer bases

GE Healthcare Being Replaced Due to Disengaged Relationships; Philips’ IntelliSpace PACS Customers on the Fence about Vue PACS

GE Healthcare has the most vulnerable customer base among measured vendors (i.e., many clients plan to leave or would leave given the chance) but still maintains a large market share. Remaining small-volume customers are more satisfied with Centricity PACS’ technology and stability, though all note the PACS feels old. They also report that the vendor overpromises, underdelivers, and has become slower to respond, leading to weakened, disengaged relationships. While GE Healthcare has been moving customers to their go-forward solution (which leverages their universal viewer), poor experiences and subsequent hesitancy have led many to consider other options.

Philips has a large customer base on the legacy IntelliSpace PACS. While satisfied with its ease of use and stability, customers have seen little development and variable support since Philips acquired Carestream. These ongoing issues have many customers on the fence about moving to the go-forward Vue PACS. Large-volume sites are particularly hesitant about functionality and proof of scalability. As a result, Vue PACS is frequently considered by IntelliSpace PACS customers but not often chosen—KLAS has validated only a few migration decisions in the last two years, while most respondents have selected other vendors.

Agfa HealthCare Sees Improvements While Rectifying Past Bumpy Rollouts of Enterprise Imaging for Radiology; Some Large IMPAX Customers Still Hesitant to Move

In the past few years, customers of Agfa HealthCare Enterprise Imaging for Radiology have seen improvements in the product’s maturity and stability as Agfa has rolled out new features and updates. They have likewise seen additional relationship investments from Agfa, who has hired a deeper bench of team members and met more frequently with customers. Customers still see significant room for improvement as issues linger from bumpy rollouts, some of which occurred a few years ago. A number of respondents report ongoing performance issues, functionality issues, and support inconsistencies. While feeling that Agfa is moving in the right direction, some customers are waiting for Agfa to deliver originally promised functionalities and have high expectations for the development of future versions. Agfa also still has a large customer base on their legacy IMPAX platform. Some large-volume sites have successfully migrated to Enterprise Imaging for Radiology, but others are waiting to make their go-forward decision until they are sure the changes are sustainable and Agfa can stay up to speed.

customer outlook large and small volume customer bases

A Note about Primarily Small-Volume Vendors

Konica Minolta and Novarad primarily play in the small-volume market, with most customers having less than 100,000 studies per year. KLAS has validated midsize customers (volumes between 100,000 and 300,000 studies per year) for each of these vendors, but they are infrequently considered by larger organizations. See the Vendor Insights section for more detail on the performance of these vendors. PaxeraHealth also primarily plays in the small-volume market. KLAS has not been able to validate a sufficient number of customers with over 50,000 studies per year to include the vendor in this report, though the limited number of customers KLAS has spoken to are satisfied.


About This Report

Each year, KLAS interviews thousands of healthcare professionals about the IT solutions and services their organizations use. For this report, interviews were conducted over the last 12 months using KLAS’ standard quantitative evaluation for healthcare software, which is composed of 16 numeric ratings questions and 4 yes/no questions, all weighted equally. Combined, the ratings for these questions make up the overall performance score, which is measured on a 100-point scale. The questions are organized into six customer experience pillars—culture, loyalty, operations, product, relationship, and value.

customer experience pillars software
about this report

Sample Sizes

Unless otherwise noted, sample sizes displayed throughout this report (e.g., n=16) represent the total number of unique customer organizations interviewed for a given vendor or solution. However, it should be noted that to allow for the representation of differing perspectives within any one customer organization, samples may include surveys from different individuals at the same organization. The table to the left shows the total number of unique organizations interviewed for each vendor or solution as well as the total number of individual respondents.

Some respondents choose not to answer particular questions, meaning the sample size for any given vendor or solution can change from question to question. When the number of unique organization responses for a particular question is less than 15, the score for that question is marked with an asterisk (*) or otherwise designated as “limited data.” If the sample size is less than 6, no score is shown. Note that when a vendor has a low number of reporting sites, the possibility exists for KLAS scores to change significantly as new surveys are collected.

Product Designations Used in This Report

  • Component [C]: Product that typically includes most but not all components that comprise a complete system or that serves only a subset of the market.
  • Not Primary [NP]: Product that is not the vendor’s lead product in the market segment but can still be purchased and is still supported. In some cases, the product may not be actively sold in the listed market segment.
author - Natalie Hopkins
Writer
Natalie Hopkins
author - Madison Moniz
Designer
Madison Moniz
author - Jill Wilcock
Project Manager
Jill Wilcock
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.

Related Segments